Acro Biomedical (ACBM) Net Cash Flow (2015 - 2025)
Acro Biomedical (ACBM) posted Net Cash Flow of -$225.0 for Q4 2025, down 105.24% on a QoQ basis from $4297.0 in Q3 2025, and little changed year-over-year from -$225.0 in Q4 2024.
Powered by 
Analysis
Acro Biomedical (ACBM) Net Cash Flow (2015 - 2025) Analysis & Trends
Acro Biomedical has reported Net Cash Flow for 11 years, with the latest figure at -$225.0 in Q4 2025.
- On a quarterly basis, Net Cash Flow changed 0.0% year-over-year to -$225.0 in Q4 2025; TTM through Dec 2025 was $3622.0, a 3522.0% increase from a year earlier, with the FY2025 full-year figure at $3622.0, up 3522.0% from the prior year.
- Net Cash Flow was -$225.0 for Q4 2025 at Acro Biomedical, down from $4297.0 in the prior quarter.
- The five-year high for Net Cash Flow was $262420.0 in Q1 2022, with the low at -$345561.0 in Q2 2022.
- Average Net Cash Flow over 5 years is -$701.25, with a median of -$225.0 recorded in 2024.
- The sharpest annual moves came in 2021 and 2022: Net Cash Flow slumped 26936.0% in 2021, then surged 4108.15% in 2022.
- Over 5 years, Net Cash Flow stood at -$59415.0 in 2021, then surged by 82.6% to -$10336.0 in 2022, then jumped by 71.99% to -$2895.0 in 2023, then surged by 92.23% to -$225.0 in 2024, then changed by 0.0% to -$225.0 in 2025.
- The last three Net Cash Flow figures came in at -$225.0 (Q4 2025), $4297.0 (Q3 2025), and -$225.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | 22.00 Mn |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | 23.00 Mn |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | 803.00 Mn |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | - |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | - |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | 43.10 Mn |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | -71.40 Mn |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | 97.30 Mn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Acro Biomedical | 1.80 Mn | 1.80 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -225.00 |
| Sep 30, 2025 | 4,297.00 |
| Jun 30, 2025 | -225.00 |
| Mar 31, 2025 | -225.00 |
| Dec 31, 2024 | -225.00 |
| Sep 30, 2024 | -225.00 |
| Jun 30, 2024 | 775.00 |
| Mar 31, 2024 | -225.00 |
| Dec 31, 2023 | -2,895.00 |
| Sep 30, 2023 | 591.00 |
| Jun 30, 2023 | 2,358.00 |
| Mar 31, 2023 | -5,530.00 |
| Dec 31, 2022 | -10,336.00 |
| Sep 30, 2022 | 4,081.00 |
| Jun 30, 2022 | -345,561.00 |
| Mar 31, 2022 | 262,420.00 |
| Dec 31, 2021 | -59,415.00 |
| Sep 30, 2021 | -60,831.00 |
| Jun 30, 2021 | 191,135.00 |
| Mar 31, 2021 | 6,236.00 |